Melanoma
-
Melanoma Risk in Childhood Cancer SurvivorsPeople treated for childhood cancer found to have twice the risk of developing melanoma as an adult.
by Cameron Walker
-
Facts and Stats
Treatment Advances Help Fuel Survival IncreasesPeople with localized esophageal cancer and advanced melanoma have benefited from improved cancer care.
by Thomas Celona
-
TILs in Solid TumorsWith the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.
by Kendall K. Morgan
-
Forward Look
Imaging Predicts Early Response to Melanoma ImmunotherapyResearch shows a scan can reveal treatment responses just one week after people with melanoma start immunotherapy.
by Anna Azvolinsky
-
TIL Therapy Amplifies the Immune System’s Attack on MelanomaThe recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Understanding Disparities in Melanoma DiagnosisBlack men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
-
Sunscreen Is Just the StartExperts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.
by Kyle Bagenstose
-
Forward Look
Tumor-infiltrating LymphocytesAdoptive T-cell therapy shows promise in treating metastatic melanoma.
by Marci A. Landsmann
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
-
Forward Look
Blood Test Could Predict Cancer Recurrence and Treatment Side EffectsProtein signatures in the blood could help guide physicians in choosing among different immunotherapy drugs.
by Anna Napolitano
